Zyversa Therapeutics, Inc.盘中异动急速下跌6.55%

市场透视02-25

北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价快速下跌6.55%。截至发稿，该股报1.14美元/股，成交量3.1843万股，换手率1.27%，振幅3.28%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.40百万美元，每股收益-2.43美元，毛利-1733.00美元，市盈率0.00倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514770659?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-25 03:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514770659","market":"us","top_or_hot":-1,"title":"Zyversa Therapeutics, Inc.盘中异动 急速下跌6.55%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价快速下跌6.55%。截至发稿，该股报1.14美元/股，成交量3.1843万股，换手率1.27%，振幅3.28%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.40百万美元，每股收益-2.43美元，毛利-1733.00美元，市盈率0.00倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zyversa Therapeutics, Inc.盘中异动 急速下跌6.55%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZyversa Therapeutics, Inc.盘中异动 急速下跌6.55%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-25 03:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价快速下跌6.55%。截至发稿，该股报1.14美元/股，成交量3.1843万股，换手率1.27%，振幅3.28%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.40百万美元，每股收益-2.43美元，毛利-1733.00美元，市盈率0.00倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZVSA","symbol_name":"ZyVersa Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b","article_id":"2514770659","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225030633a2524ebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514770659","pubTimestamp":1740423992,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.股票出现波动，股价快速下跌6.55%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为320.04%、135.25%、39.77%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ZVSA":"ZyVersa Therapeutics, Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Zyversa Therapeutics, Inc. Drops 6.55% Intraday Change","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"ZVSA":0.9},"content_text":"北京时间2025年02月25日03时06分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价快速下跌6.55%。截至发稿，该股报1.14美元/股，成交量3.1843万股，换手率1.27%，振幅3.28%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.40百万美元，每股收益-2.43美元，毛利-1733.00美元，市盈率0.00倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Nutriband Inc C/Wts (To Pur Com)、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为320.04%、135.25%、39.77%，振幅较大的相关个股有Nutriband Inc C/Wts (To Pur Com)、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)，振幅分别为176.22%、162.04%、81.92%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。 该公司拥有两个专有的全球许可药物开发平台，即Cholesterol Efflux MediatorTM，VAR 200（2-羟丙基-β-环糊精）是一种处于临床开发阶段的用于治疗肾脏疾病的注射药物。 IC 100 是一种单克隆抗体炎性体 ASC 抑制剂，处于临床前开发阶段，用于治疗炎症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514770659","isCrawlerRequest":true}

Zyversa Therapeutics, Inc.盘中异动 急速下跌6.55%

精彩评论

Zyversa Therapeutics, Inc.盘中异动急速下跌6.55%